Outcomes of Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Doxycycline vs Placebo at 12 Weeks in Patients With Mild Thyroid-Associated Ophthalmopathy: A Randomized Clinical Trial
JAMA Ophthalmol 2022 Sep 29;[EPub Ahead of Print], Y Pan, YX Chen, J Zhang, ML Lin, GM Liu, XL Xu, XQ Fan, Y Zhong, Q Li, SM Ai, W Xu, J Tan, HF Zhou, DD Xu, HY Zhang, B Xu, S Wang, JJ Ma, S Zhang, LY Gan, JT Cui, L Li, YY Xie, X Guo, N Pan-Doh, ZT Zhu, Y Lu, YX Shi, YW Xia, ZY Li, D LiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.